Survival benefit of glioblastoma patients after FDA approval of temozolomide concomitant with radiation and bevacizumab: A population-based study

por Zhu, Ping, Du, Xianglin L., Lu, Guangrong, Zhu, Jay-Jiguang
Publicado 2017

Multifocal Stevens-Johnson syndrome after concurrent phenytoin and cranial and thoracic radiation treatment, a case report

por Kandil, Abdullah O, Dvorak, Tomas, Mignano, John, Wu, Julian K, Zhu, Jay-Jiguang
Publicado 2010

Phospholipase C Beta 1: a Candidate Signature Gene for Proneural Subtype High-Grade Glioma

por Lu, Guangrong, Chang, Jeffrey T., Liu, Zheyu, Chen, Yong, Li, Min, Zhu, Jay-Jiguang
Publicado 2015

Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients with Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial

por Ram, Zvi, Kim, Chae-Yong, Hottinger, Andreas F., Idbaih, Ahmed, Nicholas, Garth, Zhu, Jay-Jiguang
Publicado 2021

Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial

por Ram, Zvi, Kim, Chae-Yong, Hottinger, Andreas F., Idbaih, Ahmed, Nicholas, Garth, Zhu, Jay-Jiguang
Publicado 2022

Drug Screening of Human GBM Spheroids in Brain Cancer Chip

por Akay, Metin, Hite, John, Avci, Naze Gul, Fan, Yantao, Akay, Yasemin, Lu, Guangrong, Zhu, Jay-Jiguang
Publicado 2018

Metformin treatment reduces temozolomide resistance of glioblastoma cells

por Yang, Seung Ho, Li, Shenglan, Lu, Guangrong, Xue, Haipeng, Kim, Dong H., Zhu, Jay-Jiguang, Liu, Ying
Publicado 2016

Detection of the MYD88 p.L265P Mutation in the CSF of a Patient With Secondary Central Nervous System Lymphoma

por Zorofchian, Soheil, Lu, Guangrong, Zhu, Jay-Jiguang, Duose, Dzifa Y., Windham, Justin, Esquenazi, Yoshua, Ballester, Leomar Y.
Publicado 2018

Full Remission of Long-Term Premenstrual Dysphoric Disorder-Like Symptoms Following Resection of a Pituitary Adenoma: Case Report

por Lu, Guangrong, Shiver, Tiana M., Blackburn, Spiros L., Yao, William C., Bhattacharjee, Meenakshi B., Zhu, Jay-Jiguang
Publicado 2020

Tumor Treating Fields (TTFields) therapy vs physicians’ choice standard-of-care treatment in patients with recurrent glioblastoma: a post-approval registry study (EF-19)

por Zhu, Jay-Jiguang, Goldlust, Samuel A., Kleinberg, Lawrence R., Honnorat, Jérôme, Oberheim Bush, Nancy Ann, Ram, Zvi
Publicado 2022

Impact of timing to initiate adjuvant therapy on survival of elderly glioblastoma patients using the SEER-Medicare and national cancer databases

por Zhu, Ping, Du, Xianglin L., Hwang, Lu-yu, Lairson, David, Li, Ruosha, Esquenazi, Yoshua, Zhu, Jay-Jiguang
Publicado 2023

NF-κB inhibitor with Temozolomide results in significant apoptosis in glioblastoma via the NF-κB(p65) and actin cytoskeleton regulatory pathways

por Avci, Naze G., Ebrahimzadeh-Pustchi, Sadaf, Akay, Yasemin M., Esquenazi, Yoshua, Tandon, Nitin, Zhu, Jay-Jiguang, Akay, Metin
Publicado 2020

Triple-drug Therapy With Bevacizumab, Irinotecan, and Temozolomide Plus Tumor Treating Fields for Recurrent Glioblastoma: A Retrospective Study

por Lu, Guangrong, Rao, Mayank, Zhu, Ping, Liang, Buqing, El-Nazer, Rasheda T., Fonkem, Ekokobe, Bhattacharjee, Meenakshi B., Zhu, Jay-Jiguang
Publicado 2019

Assessment of Glioblastoma Response in the Era of Bevacizumab: Longstanding and Emergent Challenges in the Imaging Evaluation of Pseudoresponse

por Arevalo, Octavio D., Soto, Carolina, Rabiei, Pejman, Kamali, Arash, Ballester, Leomar Y., Esquenazi, Yoshua, Zhu, Jay-Jiguang, Riascos, Roy Francisco
Publicado 2019

Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice

por Shi, Wenyin, Blumenthal, Deborah T., Oberheim Bush, Nancy Ann, Kebir, Sied, Lukas, Rimas V., Muragaki, Yoshihiro, Zhu, Jay-Jiguang, Glas, Martin
Publicado 2020

Correction to: Global post‑marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high‑grade glioma in clinical practice

por Shi, Wenyin, Blumenthal, Deborah T., Bush, Nancy Ann Oberheim, Kebir, Sied, Lukas, Rimas V., Muragaki, Yoshihiro, Zhu, Jay‑Jiguang, Glas, Martin
Publicado 2021

Presence of complete murine viral genome sequences in patient-derived xenografts

por Yuan, Zihao, Fan, Xuejun, Zhu, Jay-Jiguang, Fu, Tong-Ming, Wu, Jiaqian, Xu, Hua, Zhang, Ningyan, An, Zhiqiang, Zheng, W. Jim
Publicado 2021

Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomi...

por Zhu, Jay-Jiguang, Demireva, Petya, Kanner, Andrew A., Pannullo, Susan, Mehdorn, Maximilian, Avgeropoulos, Nicholas, Salmaggi, Andrea, Silvani, Antonio, Goldlust, Samuel, David, Carlos, Benouaich-Amiel, Alexandra
Publicado 2017

NOVEL ADJUVANT TARGETED APPROACH FOR PTEN MUTATED CHOROID PLEXUS CARCINOMA IN ADULTS: CASE REPORT AND LITERATURE REVIEW

por Nahm, Joshua K, Zhang, Jackie J, Rodriguez Quintero, Juan C, Bhattacharjee, Meena B, Nunez- Rubiano, Luis, Riascos-Castaneda, Roy, Blanco, Angel I, Day, Arthur L, Zhu, Jay-Jiguang
Publicado 2023

Analysis of cerebrospinal fluid metabolites in patients with primary or metastatic central nervous system tumors

por Ballester, Leomar Y., Lu, Guangrong, Zorofchian, Soheil, Vantaku, Venkatrao, Putluri, Vasanta, Yan, Yuanqing, Arevalo, Octavio, Zhu, Ping, Riascos, Roy F., Sreekumar, Arun, Esquenazi, Yoshua, Putluri, Nagireddy, Zhu, Jay-Jiguang
Publicado 2018